2008-2013年新西兰中毒死亡分析
该回顾性研究审查了新西兰国家验尸信息系统(NCIS)数据库2008-2013年6年间的毒物相关死亡记录。共识别1402例中毒相关死亡,死亡率为5.4/10万/年,男性(6.96/10万)高于女性(3.83/10万)。药物导致731例(52%),化学品431例(31%),多种暴露399例(28.5%)。一氧化碳是整个期间首位死因(n=303,21.6%),其死亡率从2008年1.69/10万显著降至2013年0.94/10万(IRR 0.56,95%CI 0.37-0.83),但阿片类相关死亡率和总死亡数无统计学显著变化。美沙酮是首位药物死因和总体第三位死因,其次为吗啡和可待因,佐匹克隆和氯氮平并列第六位。作者认为新西兰未经历「阿片类流行」,但中毒总体死亡率仍高,发展可及、及时、相关的毒物警戒系统有助于早期干预。
要点
- 2008-2013年新西兰中毒死亡率为5.4/10万/年,男性6.96/10万高于女性3.83/10万。
- 一氧化碳为整个期间首位死因(n=303,21.6%),死亡率从2008年1.69/10万降至2013年0.94/10万(IRR 0.56,95%CI 0.37-0.83)。
- 药物导致731例(52%),化学品431例(31%),多种暴露399例(28.5%)。
- 美沙酮是首位药物死因和总体第三位死因,其次为吗啡和可待因,佐匹克隆和氯氮平并列第六位。
- 阿片类相关死亡率和总死亡数无统计学显著变化;作者认为新西兰未经历「阿片类流行」。
适用人群与场景
- 新西兰2008-2013年6年间记录于国家验尸信息系统(NCIS)数据库的毒物相关死亡病例。
研究设计与关键结果
- 研究类型:回顾性研究,审查新西兰国家验尸信息系统(NCIS)数据库2008-2013年6年间的毒物相关死亡记录。
- 共识别1402例中毒相关死亡,死亡率为5.4例/10万人口/年;男性死亡率6.96/10万,女性3.83/10万。
- 死亡高峰在40-50岁年龄组,故意死亡比例最高在80-90岁年龄组。
- 药物导致731例死亡(52%),化学品431例(31%),多种暴露399例(28.5%)。
- 一氧化碳是整个期间首位死因(n=303,21.6%),死亡率从2008年1.69/10万显著降至2013年0.94/10万(IRR 0.56,95%CI 0.37-0.83)。
- 阿片类相关死亡率和总死亡数均无统计学显著变化。
- 美沙酮是首位药物死因和总体第三位死因,其次为吗啡和可待因,佐匹克隆和氯氮平并列第六位。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,发展可及、及时、相关的毒物警戒系统有助于早期实施干预以减少主要致死性中毒原因。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Introduction: While a number of developed countries have witnessed a decline in carbon monoxide (CO) deaths and increasing numbers of opioid-related fatalities, it is not known whether these or other trends have occurred in New Zealand. The aim of this study was, therefore, to review deaths due to poisoning in New Zealand, describe the causative substances, and identify any trends. Methods: Retrospective study reviewing New Zealand's poison-related death findings recorded in the National Coronial Information System (NCIS) database over the 6-year period 2008-2013. Results: We identified 1402 poisoning-related deaths recorded in the NCIS database representing a mortality rate of 5.4 deaths/100,000 population per year. The mortality rate due to poisoning was higher in males (6.96/100,000) than females (3.83/100,000). Fatalities peaked in the 40-50-year age group with the highest proportion of intentional deaths occurring in people aged 80-90 years. Pharmaceuticals accounted for 731 fatalities (52%) and chemicals 431 (31%), with multiple exposures occurring in 399 cases (28.5%). While CO was the leading cause of death throughout the period (n = 303, 21.6%), there was a significant reduction in the rate of CO fatalities from 1.69/100,000 population in 2008 to 0.94/100,000 in 2013 (IRR (95% CI) 2013/2008 0.56 (0.37-0.83)). There was, however, no statistically significant change in either the opioid-related death rate or the total number of deaths. Methadone was the leading pharmaceutical cause of fatality and the third most common cause overall, followed by morphine and codeine, with zopiclone and clozapine equally ranked as the sixth most common cause. Conclusion: While New Zealand has not suffered an "opioid epidemic" and has experienced a significant decline in CO deaths, the overall death rate due to poisoning has remained high. The development of accessible, timely, and relevant toxicovigilance systems would support the early implementation of interventions to reduce the leading causes of fatal poisoning.
参考来源
- Fountain JS, Reith DM, Tomlin AM, et al. Deaths by poisoning in New Zealand, 2008-2013. Clin Toxicol (Phila). 2019. PMID: 30806095. doi:10.1080/15563650.2019.1582777
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。